Hak-Hyun Nam
Founder at I-SENS, INC.
Net worth: 31 M $ as of 2024-03-30
Profile
Hak-Hyun Nam is the founder of i-SENS, Inc. which was founded in 2000.
She is currently a Non-Executive Director at Precision Biosensor, Inc., a Director at I Sense Jiangsu Co., Ltd., and a Director at CoaguSense, Inc. Dr. Nam holds a doctorate degree from Michigan State University.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
I-SENS, INC.
7.21% | 2024-04-14 | 1,985,000 ( 7.21% ) | 30 M $ | 2024-03-30 |
2023-06-29 | 100,000 ( 0.86% ) | 362 488 $ | 2024-03-30 |
Hak-Hyun Nam active positions
Companies | Position | Start |
---|---|---|
I-SENS, INC. | Founder | 2000-05-03 |
PRECISION BIOSENSOR, INC. | Director/Board Member | - |
I Sense Jiangsu Co., Ltd. | Director/Board Member | - |
CoaguSense, Inc.
CoaguSense, Inc. Electronic Equipment/InstrumentsElectronic Technology CoaguSense, Inc. operates as a diagnostic device company that develops portable point-of-care prothrombin time and international normalized ratio analyzer to directly detect blood clotting time for patients stabilized on oral anti-coagulation medications. The firm’s product is CoaguSense PT/INR monitoring system which incorporates a novel direct micromechanical clot detection technology. The company was founded in 2008 and is headquartered in Fremont, CA. | Director/Board Member | - |
Training of Hak-Hyun Nam
Michigan State University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
I-SENS, INC. | Health Technology |
PRECISION BIOSENSOR, INC. | Health Technology |
Private companies | 2 |
---|---|
I Sense Jiangsu Co., Ltd. | |
CoaguSense, Inc.
CoaguSense, Inc. Electronic Equipment/InstrumentsElectronic Technology CoaguSense, Inc. operates as a diagnostic device company that develops portable point-of-care prothrombin time and international normalized ratio analyzer to directly detect blood clotting time for patients stabilized on oral anti-coagulation medications. The firm’s product is CoaguSense PT/INR monitoring system which incorporates a novel direct micromechanical clot detection technology. The company was founded in 2008 and is headquartered in Fremont, CA. | Electronic Technology |
- Stock Market
- Insiders
- Hak-Hyun Nam